<?xml version="1.0" encoding="UTF-8"?>
<ref id="B9-molecules-26-00501">
 <label>9.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Endo</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Oguri</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Segawa</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Kawai</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Xia</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Okada</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Irie</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Fujii</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Gouda</surname>
    <given-names>H.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Development of novel AKR1C3 inhibitors as new potential treatment for castration-resistant prostate cancer</article-title>
  <source>Med. Chem.</source>
  <year>2020</year>
  <volume>63</volume>
  <fpage>10396</fpage>
  <lpage>10411</lpage>
  <pub-id pub-id-type="doi">10.1021/acs.jmedchem.0c00939</pub-id>
 </element-citation>
</ref>
